{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Vancouver",
      "address_1": "14301 Se 1st St",
      "reason_for_recall": "Labeling: Label Mixup: PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units may be potentially mislabeled as the following drug:  ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: AD70639_4, EXP: 7/28/2013.",
      "address_2": "",
      "product_quantity": "12 months",
      "code_info": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units has the following codes:   Pedigree: AD70639_7, EXP: 5/29/2014.",
      "center_classification_date": "20140120",
      "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.",
      "state": "WA",
      "product_description": "PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, Rx only, Distributed by: AidaPak Service, LLC,  NDC 00032121207.",
      "report_date": "20140129",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Aidapak Services, LLC",
      "recall_number": "D-784-2014",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "65690",
      "termination_date": "20140207",
      "more_code_info": "",
      "recall_initiation_date": "20130702",
      "postal_code": "98684-3501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}